AG
MRNA icon

Aperio Group’s Moderna MRNA Stock Holding History

Aperio Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$12.2M Buy
116,442
+8,833
+8% +$894K 0.04% 474
2020
Q3 		$7.61M Buy
107,609
+25,831
+32% +$1.8M 0.03% 568
2020
Q2 		$5.25M Buy
81,778
+27,636
+51% +$1.51M 0.02% 718
2020
Q1 		$1.62M Buy
54,142
+37,712
+230% +$868K 0.01% 1104
2019
Q4 		$321K Buy
+16,430
New +$291K ﹤0.01% 2035

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Aperio Group's MRNA Position: Q4 2020 in Review

Aperio Group increased its Moderna (MRNA) stake by 8.2% in Q4 2020, buying an estimated $894K and bringing the position to 116,442 shares worth $12.2M. The position accounts for 0.04% of the portfolio, ranked #474.

Aperio Group first reported a position in MRNA in Q4 2019 and has held it in 5 quarters since. 718 funds tracked by Wall St. Rank hold MRNA as of Q4 2020.

  • Aperio Group held 116,442 shares of Moderna worth $12.2M as of Q4 2020.
  • Aperio Group bought 8,833 Moderna shares in Q4 2020, an estimated $894K.
  • Moderna made up 0.04% of Aperio Group's portfolio in Q4 2020, its #474 holding.
  • Aperio Group first reported a position in Moderna in Q4 2019 and has held it in 5 quarters since.
  • 718 funds tracked by Wall St. Rank held Moderna as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.